About that Super Bowl ad…

The media has been turning to APC for perspective on the Hims & Hers Super Bowl ad ... a lot. Here’s just a partial list of where APC was quoted in the run-up to the Stomping of the Chiefs:

• CNBC: Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
• Bloomberg: Super Bowl Ad Selling Weight Drug Shows Wild West of Copycats
• San Francisco Chronicle: Two U.S. senators slammed an S.F. telehealth company’s Super Bowl ad. Here’s why
• 2 Urban Girls: Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad (with pick-up in MSN)
• Managed Healthcare Executive: Hims and Hers Superbowl Ad Draws Controversy Over Safety
• Inside Health Policy: Hims & Hers GLP-1 Super Bowl Ad Sparks Debate On FDA Compliance
• Medical Marketing & Media: Hims’ Super Bowl spot for compounded GLP-1 drugs draws Senate scrutiny
• Barron’s: A Super Bowl Ad Sparks Controversy and Signals a New Era in U.S. Health
• Pharmaceutical Technology: Super Bowl ad for copycat weight loss drugs stokes pharma power debate
• Fortune: Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

It’s still going on. On the Tuesday after the game, ABC News ran “Super Bowl ad for Hims & Hers' weight loss drug sparks backlash” that included “experts” from TikTok complaining about the commercial, but with APC’s perspective adding a little, well, perspective.